Mechanism of Melphalan-induced B7-1 Gene Expression in P815 Tumor Cells
Overview
Affiliations
We have previously shown that exposure of P815 tumor cells to melphalan (L-phenylalanine mustard; L-PAM) leads to up-regulation of B7-1 surface expression, and this L-PAM-induced up-regulation requires de novo RNA synthesis and is associated with accumulation of B7-1 mRNA. Here we show that the effect of L-PAM on B7-1 surface expression can be mimicked by exposing P815 tumor cells to oxidative stress but not to heat shock. Moreover, the antioxidant N-acetyl-L-cysteine prevented the L-PAM-induced accumulation of B7-1 mRNA in P815 tumor cells, suggesting that reactive oxygen species are involved in the transcriptional regulation of L-PAM-induced B7-1 gene expression. Although AP-1 and NF-kappaB are regarded as redox-sensitive transcription factors and the promoter/enhancer region of the B7-1 gene contains an AP-1 and an NF-kappaB binding site, exposure of P815 tumor cells to L-PAM led to rapid and transient activation only of NF-kappaB, but not AP-1, that bound specifically to a probe containing the respective binding site in the murine or human B7-1 gene. Moreover, exposure of P815 tumor cells to a cell-permeable peptide that selectively inhibits NF-kappaB activation by blocking the activation of the IkappaB-kinase complex was found to inhibit the L-PAM-induced B7-1 mRNA accumulation, indicating that NF-kappaB activation is essential for the L-PAM-induced B7-1 gene expression. Taken together, these results indicate that L-PAM leads to activation of B7-1 gene expression by activating NF-kappaB via a pathway that involves reactive oxygen species.
The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J Sci Rep. 2018; 8(1):17322.
PMID: 30470792 PMC: 6251900. DOI: 10.1038/s41598-018-35798-2.
Jain N, Khullar B, Oswal N, Banoth B, Joshi P, Ravindran B Dis Model Mech. 2016; 9(6):707-17.
PMID: 27125280 PMC: 4920147. DOI: 10.1242/dmm.023440.
Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.
Nguyen A, Ho L, Wan Y Front Oncol. 2014; 4:145.
PMID: 24967214 PMC: 4052116. DOI: 10.3389/fonc.2014.00145.
Chemoimmunotherapy: reengineering tumor immunity.
Chen G, Emens L Cancer Immunol Immunother. 2013; 62(2):203-16.
PMID: 23389507 PMC: 3608094. DOI: 10.1007/s00262-012-1388-0.
Emens L Cancer J. 2010; 16(4):295-303.
PMID: 20693839 PMC: 2919833. DOI: 10.1097/PPO.0b013e3181eb5066.